GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alembic Pharmaceuticals Ltd (BOM:533573) » Definitions » Shiller PE Ratio

Alembic Pharmaceuticals (BOM:533573) Shiller PE Ratio : 24.42 (As of May. 27, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Alembic Pharmaceuticals Shiller PE Ratio?

As of today (2024-05-27), Alembic Pharmaceuticals's current share price is ₹946.30. Alembic Pharmaceuticals's E10 for the quarter that ended in Mar. 2024 was ₹38.75. Alembic Pharmaceuticals's Shiller PE Ratio for today is 24.42.

The historical rank and industry rank for Alembic Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

BOM:533573' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.45   Med: 20.67   Max: 27.4
Current: 24.51

During the past years, Alembic Pharmaceuticals's highest Shiller PE Ratio was 27.40. The lowest was 13.45. And the median was 20.67.

BOM:533573's Shiller PE Ratio is ranked worse than
50.09% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.51 vs BOM:533573: 24.51

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alembic Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹9.070. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹38.75 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alembic Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for Alembic Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alembic Pharmaceuticals Shiller PE Ratio Chart

Alembic Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 21.79 13.71 25.35

Alembic Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.71 17.09 20.81 19.80 25.35

Competitive Comparison of Alembic Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Alembic Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alembic Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alembic Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alembic Pharmaceuticals's Shiller PE Ratio falls into.



Alembic Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Alembic Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=946.30/38.75
=24.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alembic Pharmaceuticals's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Alembic Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9.07/153.0345*153.0345
=9.070

Current CPI (Mar. 2024) = 153.0345.

Alembic Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 3.430 94.103 5.578
201409 4.100 96.780 6.483
201412 3.750 96.780 5.930
201503 3.730 97.163 5.875
201506 3.720 99.841 5.702
201509 15.300 101.753 23.011
201512 14.260 102.901 21.208
201603 4.820 102.518 7.195
201606 5.500 105.961 7.943
201609 6.360 105.961 9.185
201612 4.590 105.196 6.677
201703 4.940 105.196 7.186
201706 3.540 107.109 5.058
201709 6.450 109.021 9.054
201712 6.930 109.404 9.694
201803 4.980 109.786 6.942
201806 4.800 111.317 6.599
201809 10.610 115.142 14.102
201812 9.010 115.142 11.975
201903 6.580 118.202 8.519
201906 6.560 120.880 8.305
201909 13.060 123.175 16.226
201912 12.420 126.235 15.057
202003 11.920 124.705 14.628
202006 15.990 127.000 19.268
202009 17.240 130.118 20.276
202012 14.880 130.889 17.398
202103 11.080 131.771 12.868
202106 8.370 134.084 9.553
202109 8.340 135.847 9.395
202112 8.740 138.161 9.681
202203 1.110 138.822 1.224
202206 -3.350 142.347 -3.602
202209 6.780 144.661 7.172
202212 6.200 145.763 6.509
202303 7.760 146.865 8.086
202306 6.140 150.280 6.253
202309 6.950 151.492 7.021
202312 9.180 152.924 9.187
202403 9.070 153.035 9.070

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alembic Pharmaceuticals  (BOM:533573) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Alembic Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Alembic Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alembic Pharmaceuticals (BOM:533573) Business Description

Traded in Other Exchanges
Address
Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Alembic Pharmaceuticals (BOM:533573) Headlines

No Headlines